February 28, 2022

Prestige Scientific Announces Successfully Completed Search for a Director of Assay Development

Completed Searches

Wilmington, NC. – Prestige Scientific is excited to announce the successful completion of a search for a Director of Assay Development for our biotechnology partner that is developing antibody therapies in the inflammation and rheumatology space. Reporting directly to the VP of Discovery and Translational, this Director of Assay Development will build and lead the newly formed Antibody Discovery and Technologies function within Discovery Research. They will be responsible for initiating antibody campaigns and for leading all efforts aimed at characterizing sequences to select lead candidates across multiple projects. This critical hire will also assume project leadership of 1-2 target discovery efforts and will be responsible for all activities aimed at transitioning lead candidates into development.

Client Objectives: Our partner is charting a new path for patients and families impacted by HAE and rare allergic and immunological diseases. Their goal is to develop therapeutics that bring meaningful changes to patients’ lives by pushing the boundaries of what is currently perceived as the standard of care for rare and niche diseases in allergy and immunology.

Project: Prestige Scientific presented the candidate hired within 60 days of starting the project and successfully completed the search within 90 days of project launch. Congratulations to Matt Cruickshank and Melissa Acevedo for leading this search! Checkout more of our completed searches on LinkedIn.

About Prestige Scientific:

Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.